Insurance evidence is one of the quickest ways to lose momentum in a MedTech bid. Not because suppliers lack cover, but because the way it is presented can leave buyers uncertain about risk, scope, and accountability.
At Bidding, we see this repeatedly in NHS competitions: strong technical and clinical submissions held back by unclear certificates, mismatched limits, or product liability that does not align with the actual delivery model. This guide shows what buyers tend to look for, what “good” evidence looks like, and how to avoid common compliance traps.
In NHS procurement, insurance is not a box-tick exercise. It is a shortcut to reassurance.
Evaluators are typically trying to confirm four things, quickly:
If the evidence does not make it easy to confirm “cover type, limit, entity, dates, and scope fit”, you are more likely to get clarifications. In tighter processes, you are more likely to be marked non-compliant.
The exact requirements vary by buyer and route, but NHS-led competitions tend to ask for a consistent core set. The key is matching the cover to what you actually do, not what your product brochure implies.
EL is often straightforward, but it is also frequently submitted incorrectly.
Buyers usually want:
Common issues include submitting the certificate for a parent company when the bidding entity is a subsidiary, or providing an expired certificate that is “in renewal”.
PL is usually required when your staff may be on NHS sites, interacting with patients, clinicians, estates teams, or third parties.
This is especially relevant for:
Where tenders specify a limit, it is often expressed as “any one occurrence” or “any one claim”. Make sure your certificate wording matches the buyer’s language. If your policy is expressed differently, explain it clearly and attach the schedule that evidences equivalence.
Product liability is the centre of gravity for MedTech bids. Buyers want confidence that if something goes wrong with the device, the NHS will not be left carrying avoidable risk.
The main causes of confusion are:
If your product is supplied alongside services, do not assume product liability alone will address the full risk picture. The bid response should reflect the full delivery model.
PI often appears where the solution includes advice, design, integration, configuration, or services that could create financial loss even without physical harm.
PI is particularly relevant for:
If the scope includes a combination of device and service, a clearer narrative often helps: product liability for device-related injury or damage, and PI for service-related errors, omissions, or design issues.
Not every MedTech bid needs cyber insurance, but NHS buyers increasingly expect a mature stance where devices are connected, data is processed, or remote access exists.
Cyber can become relevant for:
If cyber cover is requested, keep the response aligned to the scope and information security position. Overstating capability can create its own risk during due diligence.
NHS routes to market often converge on similar insurance expectations, even if the procurement format differs. The practical reality is that once you are in “NHS frameworks” and catalogue-style environments, risk language can become more standardised.
One strong signal in the NHS ecosystem is the use of indemnity and insurance expectations through mechanisms such as the NHS Supply Chain Master Indemnity Agreement approach and register. For suppliers whose products are sold through those routes, the minimums and structure can shape what buyers expect to see in evidence packs. This is why it is worth understanding the broader direction of travel, including the NHS Supply Chain Master Indemnity Agreement register approach for suppliers. NHS
Frameworks, DPS routes, and Trust-led tenders can still differ. The bid advantage comes from planning around the higher bar so your insurance pack rarely becomes the constraint.
“MedTech supplier” can mean very different legal and operational roles. Product liability exposure changes depending on whether you are manufacturing, distributing, importing, servicing, or bundling digital elements.
A buyer will want to know who is accountable for:
If you are not the manufacturer, your bid still needs to show how liability flows back to the accountable party, and how your own cover responds while issues are investigated or resolved. This is where clarity matters more than volume.
Where relevant, acknowledge the UK regulatory framework and roles, including responsibilities that can apply to importers, distributors, and UK Responsible Persons for some products.
A high proportion of NHS MedTech contracts include more than the device.
If your scope includes installation, configuration, preventative maintenance, or user training, you should expect insurance requirements to reflect that blended model. This can also affect how buyers interpret “product liability” versus “service liability”.
A strong bid narrative typically does three things:
Many NHS and public sector processes still use selection-stage questions that resemble the Standard Selection Questionnaire approach, even where the template is adapted. This is one reason insurance evidence can appear early, with limited appetite for ambiguity.
At selection stage, buyers commonly want:
At award or mobilisation stage, they may request:
If your approach relies on “we can increase cover if awarded”, treat that as a managed plan, not a statement. State what will change, when, how it will be evidenced, and who is responsible.
Some issues recur so often that they are worth checking before you press submit:
Where you spot a mismatch, the best approach is direct and structured. State the requirement, state your current position, explain the gap, and show the mitigation.
This is where bids are won or lost on clarity. A buyer should not need to interpret your documents.
Use a simple pattern that can be replicated across tenders:
Summary table
Include: cover type, limit, basis (per claim or aggregate), insurer, policy number, expiry, insured entity.
Scope alignment paragraph
Confirm how the covers align to the services, device supply model, on-site activity, and any digital elements.
Evidence list
Name what you have attached: certificates, schedules, endorsements, broker letters.
This structure can sit within a broader bid-readiness approach, especially when you are preparing a reusable compliance pack to support being bid-ready.
Some NHS tenders specify insurance limits that feel high relative to contract value. If the requirement is disproportionate, you can still respond in a way that protects evaluation confidence.
Options that are often credible when presented properly:
Keep the tone calm and factual. Avoid implying you are currently non-compliant without a mitigation plan.
Insurance and liability evidence sits at the intersection of commercial, legal, quality, and delivery. It is rarely owned by one team, and that is why it can become a bottleneck close to deadline.
At Bidding, we support suppliers bidding into healthcare tenders by turning insurance requirements into a clean, evidence-led narrative that evaluators can verify quickly.
What this typically includes:
We extract every insurance and indemnity requirement from the ITT, contract terms, and schedules, then map it to:
Insurance sections often require broker input, legal review, and sign-off from quality or operations. Our bid management approach keeps this moving so the compliance pack does not become the long pole in the tent.
If you are applying for frameworks, we help you build an evidence library that stands up across multiple competitions, rather than rewriting the same section every time. That also helps you manage the internal effort and the true cost of bidding across a pipeline of NHS opportunities.
Often, yes. Even if the manufacturer holds primary product liability, NHS buyers may expect the contracting supplier to hold product-related cover, and to show how liability and recourse work in practice. The bid should make clear how claims are handled, what your policy covers, and how issues flow back to the manufacturer.
State your current limits clearly, then set out a practical mitigation plan. If you intend to increase cover on award, show that it is achievable with broker confirmation and a timeline. Avoid vague commitments with no evidence.
It can. Software-driven risk can increase PI and cyber relevance, even where physical product liability remains important. Where your solution includes integration, configuration, or clinical workflow impact, PI becomes more than a formality.
Selection tends to prioritise confirmation and certificates, while award and mobilisation may require fuller schedules and endorsements. Many buyers use selection-style prompts aligned to government SQ approaches, even when the document is adapted.
Not universally. It is route-dependent, and different buyers apply different contracting approaches. But it is a meaningful signal of how the NHS thinks about supplier indemnity and minimum expectations in some catalogue and supply-chain contexts, which is why it is worth understanding.
Before you submit, sense-check your insurance pack against these points:
If you want a second pair of expert eyes on your insurance and product liability section, Bidding can help. We work with MedTech suppliers to reduce clarification risk, tighten compliance, and present evidence in a way NHS evaluators can trust. If you are targeting NHS-led opportunities and need extra capacity, Bidding is ready to support you from early readiness through to submission.
Bidding Ltd © 2026
